MER Primary Care Conferences Internal Medicine for Primary Care Cardio Endo Nephro Sep 18-20, 2026

This MER review connects cardiovascular care with endocrine and renal problems commonly managed in primary care. The September 18–20, 2026 meeting at The Ritz-Carlton, Laguna Niguel begins with calcium disorders, metabolic bone disease and osteoporosis, followed by chronic kidney disease, glomerulonephritis and diabetic kidney disease. Electrolyte cases lead into cardiovascular prevention, coronary artery disease assessment, heart failure and arrhythmias. The program is intended for clinicians reviewing diagnostic reasoning and treatment options across these related specialties. Its complete agenda appears below, preserving all twelve session titles and their supporting topic lists in the original daily order.

Package scope: The agenda describes the source conference, not a verified inventory of delivered files. Recording coverage, formats and completeness have not been independently checked. MER registration, publisher accounts and live participation are not included.

Topics

Day 1 — Friday, September 18, 2026

Endocrinology

1. Disorders of Calcium Metabolism

• Calcium homeostasis and regulation
• Causes of hypercalcemia
• Diagnostic evaluation of calcium abnormalities
• Treatment of calcium metabolism disorders

2. Metabolic Bone Disease

• Disorders of mineral and vitamin D metabolism
• Calcium and phosphorus regulation
• Osteomalacia and Paget’s disease
• Parathyroid disorders and bone health

3. Osteoporosis

• Epidemiology and pathophysiology of osteoporosis
• DEXA scan interpretation
• FRAX fracture risk assessment
• Current pharmacological treatment options

Nephrology

4. Should All Patients with CKD be on SGLT2 Inhibitors?

• Role of SGLT2 inhibitors in chronic kidney disease
• Kidney and cardiovascular benefits
• Guideline-directed medical therapy
• Treatment considerations in patients with and without diabetes

5. Glomerulonephritis 101

• Recognition and diagnosis of glomerulonephritis
• Differentiating glomerular diseases
• IgA nephropathy
• Emerging and approved therapeutic approaches

Day 2 — Saturday, September 19, 2026

Nephrology

6. Managing Diabetic Kidney Disease: New Insights and Therapies

• Early identification of diabetic kidney disease
• Diagnosis and progression of chronic kidney disease
• New treatment strategies
• Nonsteroidal mineralocorticoid receptor antagonists
• GLP-1 receptor agonists and kidney outcomes

7. Primary Care Primer on Electrolytes

• Sodium disorders
• Potassium imbalances
• Bicarbonate and acid-base abnormalities
• Case-based diagnosis and treatment

Endocrinology

8. Endocrinology Cases: Calcium Disorders and Osteoporosis

• Clinical case discussions
• Diagnostic and therapeutic decision-making
• Calcium abnormalities
• Individualized osteoporosis treatment planning

Cardiology

9. Primary Prevention of Cardiometabolic CVD

• Cardiovascular risk assessment
• Lipid and cholesterol guidelines
• Metabolic syndrome and obesity
• Lifestyle modification and exercise
• Preventive pharmacotherapy
• Cardiac rehabilitation

10. Work-up of Patients with Suspected CAD

• Coronary artery disease risk factors
• Chest pain evaluation
• ACC/AHA chest pain guidance
• ECG, echocardiography, and cardiac imaging
• CT-based evaluation
• Special populations with suspected CAD

Day 3 — Sunday, September 20, 2026

Cardiology

11. Heart Failure

• Heart failure classification and staging
• HFrEF and HFpEF
• ACC/AHA guideline-based management
• ACE inhibitors, ARBs, ARNI, and beta-blockers
• Mineralocorticoid receptor antagonists and SGLT2 inhibitors
• NT-proBNP and other biomarkers
• Device therapy and referral considerations
• Acute decompensated heart failure

12. Arrhythmias

• Evaluation of palpitations
• Common cardiac arrhythmias
• Atrial fibrillation diagnosis and treatment
• Stroke risk assessment
• Anticoagulation strategies
• Rate versus rhythm control
• Ventricular arrhythmias and referral indications